We previously showed that BBR inhibited growth and invasion of NSCLC cells through reduction of 3‐phosphoinositide‐dependent protein kinase‐1 (PDPK1) and transcription factor SP1 expressions; this resulted in a reduction of DNA methyltransferase 1 (DNMT1) expression. This evidence concerns the gene DNMT1 and non-small cell lung carcinoma.